Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02361190 · ClinicalTrials.gov registry record · NA
Effects of Fast Acting Testosterone Nasal Spray on Anxiety
A NA study, sponsored by University of Texas at Austin.
- Completed
- Registry status
- NA
- Development phase
- 96
- Enrollment target
NCT02361190 is a NA study that has completed, run by University of Texas at Austin. The registered enrollment target is 96 participants.
The verdict
NCT02361190, a NA study, has completed, sponsored by University of Texas at Austin.
- COMPLETED
- Registry status
- NA
- Development phase
- 96 participants
- Enrollment target
Study Summary
The proposed study will test the effects of a fast-acting testosterone nasal spray on the fear reactions of young men to two distinct anxiety challenges (social and nonsocial) using a double-blind randomized experimental design.
Interventions
- DRUG Placebo
- DRUG Testosterone
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 96 participants |
| Start Date | 2015-02 |
| Est. Completion | 2016-05 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02361190
The ClinicalTrials.gov registry entry for NCT02361190 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 96 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Texas at Austin, which has 257 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Placebo is the first listed.
NCT02361190 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02361190 about?
NCT02361190 is a clinical study titled "Effects of Fast Acting Testosterone Nasal Spray on Anxiety". The proposed study will test the effects of a fast-acting testosterone nasal spray on the fear reactions of young men to two distinct anxiety challenges (social and nonsocial) using a double-blind randomized experimental design.
What is the current status of trial NCT02361190?
This trial is currently completed. It is a NA study. The enrollment target is 96 participants. The study started on 2015-02. Estimated completion is 2016-05.
What interventions are being tested in trial NCT02361190?
The interventions under investigation include: Placebo (DRUG), Testosterone (DRUG).
Who is sponsoring clinical trial NCT02361190?
This trial is sponsored by University of Texas at Austin, which has 257 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.